Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection. [electronic resource]
Producer: 20170117Description: 1332-3 p. digitalISSN:- 1600-6143
- Aged
- Antineoplastic Agents -- therapeutic use
- CTLA-4 Antigen -- antagonists & inhibitors
- Graft Rejection -- etiology
- Graft Survival
- Humans
- Kidney Failure, Chronic -- complications
- Kidney Transplantation -- adverse effects
- Male
- Melanoma -- drug therapy
- Postoperative Complications
- Prognosis
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Risk Factors
- Skin Neoplasms -- drug therapy
- Transplant Recipients
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.